Cell-based therapies for Parkinson's disease

SC Dyson, RA Barker - Expert Review of Neurotherapeutics, 2011 - Taylor & Francis
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …
被引用次数：52 相关文章

Cell-based therapies for Parkinson's disease

SC Dyson, RA Barker - Expert Review of Neurotherapeutics, 2011 - search.proquest.com
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …

Cell-based therapies for Parkinson'a [euro][TM] s disease

SC Dyson, RA Barker - Expert Review of Neurotherapeutics, 2011 - go.gale.com
Parkinson'âs disease (PD) is one of the most common degenerative diseases of the CNS,
with a worldwide prevalence of approximately 1% in those over 60 years of age. The first …

[引用][C] Cell-based therapies for Parkinson's disease

SC Dyson, RA Barker - Expert Review of Neurotherapeutics, 2011 - cir.nii.ac.jp

Cell-based therapies for Parkinson's disease

SC Dyson, RA Barker - Expert review of …, 2011 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …

Cell-based therapies for Parkinson's disease.

SC Dyson, RA Barker - Expert Review of Neurotherapeutics, 2011 - europepmc.org
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …